 insufﬁciency: worldwide results of the
RELIEF study. Reﬂux assEssment and quaLity of lIfe improvEment
with micronized Flavonoids. Angiology 2000;51(1):31-7.
112. Allaert FA. Meta-analysis of the impact of the principal venoactive
drugs agents on malleolar venous edema. Int Angiol 2012;31:310-5.
113. Carpentier P, van Bellen B, Karetova D, et al. Clinical efﬁcacy
and safety of a new 1000-mg suspension versus twice-daily 500mg tablets of MPFF in patients with symptomatic chronic
venous disorders: a randomized controlled trial. Int Angiol
2017;36:402-9.
114. Coleridge-Smith P, Lok C, Ramelet AA. Venous leg ulcer: a metaanalysis of adjunctive therapy with micronized puriﬁed ﬂavonoid
fraction. Eur J Vasc Endovasc Surg 2005;30:198-208.
115. Ramelet AA, Boisseau MR, Allegra C, et al. Veno-active drugs in
the management of chronic venous disease. An international
consensus statement: current medical position, prospective
views and ﬁnal resolution. Clin Hemorheol Microcirc 2005;33:
309-19.
116. Pokrovsky AV, Saveljev VS, Kirienko AI, et al. Surgical correction of
varicose vein disease under micronized diosmin protection (results
of the Russian multicenter controlled trial DEFANS). Angiol Sosud
Khir 2007;13:47-55.
117. Mazzaccaro D, Muzzarelli L, Modafferi A, Righini PC, Settembrini AM,
Nano G. Use of venoactive drugs after surgery for varicose veins: a
preliminary study. Int Angiol 2018;37:79-84.
118.